BC

Birchview Capital Portfolio holdings

AUM $171M
1-Year Est. Return 85.36%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+85.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$171M
AUM Growth
+$38.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
80
New
Increased
Reduced
Closed

Top Buys

1
+$6.27M
2
+$3.52M
3
+$3.32M
4
BCYC
Bicycle Therapeutics
BCYC
+$2.28M
5
SLDB icon
Solid Biosciences
SLDB
+$2.22M

Top Sells

1
+$2.12M
2
+$1.91M
3
+$1.85M
4
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$1.16M
5
PRTA icon
Prothena Corp
PRTA
+$1.1M

Sector Composition

1 Healthcare 75.96%
2 Technology 19.61%
3 Energy 3.55%
4 Materials 0.54%
5 Financials 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMCI icon
51
Treace Medical Concepts
TMCI
$88.6M
$556K 0.33%
226,947
+50,000
LUNG icon
52
Pulmonx
LUNG
$66.4M
$554K 0.32%
+250,573
RAPT icon
53
RAPT Therapeutics
RAPT
$508K 0.3%
+15,000
GOSS icon
54
Gossamer Bio
GOSS
$121M
$428K 0.25%
138,176
ATEC icon
55
Alphatec Holdings
ATEC
$1.9B
$380K 0.22%
18,058
-14,942
OM icon
56
Outset Medical
OM
$63M
$367K 0.21%
98,913
+20,329
APLS icon
57
Apellis Pharmaceuticals
APLS
$2.58B
$352K 0.21%
14,000
LQDA icon
58
Liquidia Corp
LQDA
$3B
$345K 0.2%
+10,000
CADL icon
59
Candel Therapeutics
CADL
$355M
$339K 0.2%
60,000
VYGR icon
60
Voyager Therapeutics
VYGR
$219M
$294K 0.17%
74,918
-60,000
TRIN icon
61
Trinity Capital
TRIN
$1.14B
$293K 0.17%
+20,000
INBX icon
62
Inhibrx
INBX
$1.03B
$292K 0.17%
3,698
-28,000
KBDC
63
Kayne Anderson BDC
KBDC
$951M
$286K 0.17%
+20,000
CGEM icon
64
Cullinan Oncology
CGEM
$922M
$207K 0.12%
20,000
ELUT icon
65
Elutia
ELUT
$47.4M
$182K 0.11%
263,018
-448,157
ALMS
66
Alumis Inc
ALMS
$3.45B
$97.6K 0.06%
10,000
DCGO icon
67
DocGo
DCGO
$68.7M
$43.8K 0.03%
49,908
-714,154
ZNTL icon
68
Zentalis Pharmaceuticals
ZNTL
$142M
$22.9K 0.01%
17,000
GH icon
69
Guardant Health
GH
$12.1B
– –
-6,000
IFRX icon
70
InflaRx
IFRX
$62.3M
– –
-50,000
KIDS icon
71
OrthoPediatrics
KIDS
$447M
– –
-16,000
KNSA icon
72
Kiniksa Pharmaceuticals
KNSA
$3.49B
– –
-30,000
KPTI icon
73
Karyopharm Therapeutics
KPTI
$162M
– –
-27,985
SRRK icon
74
Scholar Rock
SRRK
$4.71B
– –
-26,000
APLT
75
DELISTED
Applied Therapeutics
APLT
– –
-225,000
1 2
3
4